
Toddler Formulas
These marketing claims have experts throwing a tantrum.
Plowden et al. v. Similasan Corp.
23-cv-2511, D. Colo.
(Sept. 2023)
Similasan Eye Relief products
Marketing products as able to relieve various eye issues – including watery eyes, grittiness, redness, strain, and burning – when the company does not have FDA approval to make such drug claims and has not shown that the products are “generally recognized as safe and effective”
Settled
(Preliminarily approved)
https://www.homeopathiceyedropsettlement.com/home
These marketing claims have experts throwing a tantrum.
Some members of Congress want to kill a popular “click-to-cancel” rule.
How much does this monthly book subscription actually cost?
Companies should not be able to trap consumers into subscriptions that they do not want.
Getting out may not be as easy as signing up.